RETIVUE

Medtech · Private

EntireEyeScope, a 3D stereo endoscopic viewing system for intraocular retinal surgery visualization

New patent ·
Claim this profile

Follows are private to you and power your alerts

Updated

Sector
Medtech
Total capital
$4.9M
Federal grants
$4.9M
7 awards · 2015–2024
Rank in peer group#162 of 538
Private capital raised
None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
Federal contracts
None on recordNo federal contract awards found.
Granted patents
8
8 pending · first 2019
Rank in peer group#74 of 538

Capital timeline

20152017201920212023FEDERAL ↑EQUITY ↓Cumulative $4.9M$903K$604K$927K$848K$634K$634K
20152017201920212023FEDERAL ↑EQUITY ↓Cumulative $4.9M$903K$927K$848K$634K

Latest events

  • Federal grantHealth and Human S · Phase I · RetiVue EntireEyeScope: A high resolution, top-down view, stereo, endoscopic viewing system for vitreoretinal surgery$350K
  • Federal grantHealth and Human S · Phase II · RetiVue WF - A Handheld, High-Resolution, Widefield Retinal Imager$634K
  • Federal grantHealth and Human S · Phase II · RetiVue WF - A Handheld, High-Resolution, Widefield Retinal Imager$634K
  • Federal grantHealth and Human S · Phase II · RetiVue DR, a point and shoot, non-mydriatic, widefield retinal camera for diabetic eye screening$848K
  • Federal grantHealth and Human S · Phase II · RetiVue DR, a point and shoot, non-mydriatic, widefield retinal camera for diabetic eye screening$927K
  • Federal grantHealth and Human S · Phase II · RetiVue WF - A Handheld, High-Resolution, Wide-field Retinal Imager$604K
  • Federal grantHealth and Human S · Phase II · RetiVue WF - A Handheld, High-Resolution, Wide-field Retinal Imager$903K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 538 peers

Line = median

Medtech · Device

  • Federal grants#162 · top 30%
  • Granted patents#74 · top 14%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

No founders are linked to this company yet.

Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.

Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026

Claim this profile to add your team

What it has protected

USPTO · 8 granted of 16
Show all 16 patent records
  • CLAIRWAYS LLCSimilar federal contract value in Medtech · null in contracts
  • PZA INNOVATION LLCSimilar federal contract value in Medtech · null in contracts
  • PERFUSIO CORP.Similar federal contract value in Medtech · null in contracts
  • Leith Medical, Inc.Similar federal contract value in Medtech · null in contracts
  • ADAPTILENS, INC.Similar federal contract value in Medtech · null in contracts
  • EXCELSIOR BIOFILMS, LLCSimilar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .